Platelet CD154 Potentiates Interferon-α Secretion by Plasmacytoid Dendritic Cells in Systemic Lupus Erythematosus
P. Duffau(Centre National de la Recherche Scientifique), Patrick Blanco(Centre National de la Recherche Scientifique), Frédéric Batteux(Inserm), Bernard Weil(Délégation Paris 5), Cécile Bordes(Centre National de la Recherche Scientifique), Carole Nicco(Inserm), Isabelle Douchet(Centre National de la Recherche Scientifique), Christophe Richez(Centre National de la Recherche Scientifique), Estibaliz Lazaro(Centre National de la Recherche Scientifique), Jean‐Luc Pellegrin(Centre National de la Recherche Scientifique), Claire Goulvestre(Délégation Paris 5), Julien Sénéschal(Hôpital Saint-André), Jean‐François Viallard(Centre Hospitalier Universitaire de Bordeaux), Jean‐François Moreau(Centre National de la Recherche Scientifique)
Cited by 219
Related Papers
Trial of Anifrolumab in Active Systemic Lupus Erythematosus
|New England Journal of Medicine|2019|1.3k
<i>MUC5B</i> Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease
|New England Journal of Medicine|2018|501
Further characterization of clinical and laboratory features in VEXAS syndrome: large‐scale analysis of a multicentre case series of 116 French patients*
|British Journal of Dermatology|2021|414
Rheumatic disorders associated with immune checkpoint inhibitors in patients with cancer—clinical aspects and relationship with tumour response: a single-centre prospective cohort study
|Annals of the Rheumatic Diseases|2017|302
European Dermatology Forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes
|Journal of the European Academy of Dermatology and Venereology|2017|261